"It's been a very, very small budget," Klimas said about funds devoted to discovering treatments. "I had looked up male pattern baldness … $18 million for male pattern baldness [but only] $3 million for chronic fatigue syndrome, an illness that affects 1 million people in this country that has at least 25 percent of them out of work and on disability."
Studies show that fewer than 20 percent of CFS patients in the United States have been properly diagnosed. Klimas said that's because many doctors tell patients their symptoms are psychological. The name itself is a problem, she explained.